Spermatocele

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Region Jamtland Harjedalen Academic
    BUPIVACAINE HYDROCHLORIDE; LAUROMACROGOL 400; LIDOCAINE HYDROCHLORIDE; MEPIVACAINE HYDROCHLORIDE; ROPIVACAINE HYDROCHLORIDE
    2022-502284-38-00 1 country 2025 n=300
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Region Jamtland Harjedalen Academic 1 Phase III 1
New trials by year
2025
1
← All indication landscapes